Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 30.83B | 32.04B | 32.84B | 30.16B | 26.62B |
Gross Profit | 6.69B | 6.86B | 6.72B | 6.76B | 7.32B |
EBITDA | 1.98B | 1.70B | 1.58B | 1.64B | 2.17B |
Net Income | 821.00M | 700.00M | 537.00M | 526.00M | 903.00M |
Balance Sheet | |||||
Total Assets | 29.07B | 27.77B | 26.68B | 26.06B | 26.04B |
Cash, Cash Equivalents and Short-Term Investments | 6.16B | 6.56B | 5.70B | 5.88B | 7.04B |
Total Debt | 2.95B | 3.04B | 3.16B | 3.33B | 3.43B |
Total Liabilities | 8.17B | 8.17B | 7.85B | 7.79B | 7.88B |
Stockholders Equity | 20.90B | 19.60B | 18.83B | 18.27B | 18.16B |
Cash Flow | |||||
Free Cash Flow | -16.00M | 1.23B | 256.00M | -792.00M | 1.14B |
Operating Cash Flow | 855.00M | 2.00B | 1.11B | -53.00M | 1.63B |
Investing Cash Flow | -971.00M | -677.00M | -854.00M | -720.00M | -365.00M |
Financing Cash Flow | -367.00M | -390.00M | -437.00M | -371.00M | -370.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥10.52B | 12.36 | 6.74% | 8.57% | 15.83% | ||
79 Outperform | ¥8.53B | 13.37 | 3.43% | -0.85% | -33.24% | ||
78 Outperform | ¥120.75B | 9.94 | 2.57% | 9.10% | 92.69% | ||
73 Outperform | ¥19.88B | 23.24 | 4.91% | 16.98% | -7.36% | ||
68 Neutral | ¥3.77B | 3.18 | ― | -9.90% | 27.50% | ||
68 Neutral | ¥72.34B | 21.78 | 1.38% | -6.97% | ― | ||
65 Neutral | $15.05B | 6.94 | 3.01% | 5.34% | 4.29% | -62.50% |